Fred B. Craves - 11 Jun 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Director
Signature
/s/ Mardi Dier, as Attorney-in-Fact
Issuer symbol
MDGL
Transactions as of
11 Jun 2024
Transactions value $
$0
Form type
4
Filing time
13 Jun 2024, 21:45:55 UTC
Previous filing
16 May 2024
Next filing
27 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Gift $0 -39K -9.43% $0.00 374K 11 Jun 2024 Direct
transaction MDGL Common Stock Gift $0 -45.9K -80.35% $0.00 11.2K 11 Jun 2024 See Footnote F1
holding MDGL Common Stock 1.26K 11 Jun 2024 See Footnote F2
holding MDGL Common Stock 18K 11 Jun 2024 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust.
F2 (2) These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.
F3 Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.